Green Park Collaborative and Allergy & Asthma Network Publish a Core Outcome Set for Clinical Trials in Moderate to Severe Asthma
News provided by
Share this article
Share this article
core across all phase 3 and 4 clinical drug trials for moderate to severe asthma.
The report, published in the Annals of Allergy, Asthma and Immunology, describes the multi-stakeholder consensus process used to prioritize nearly 100 outcomes down to a final set of five core outcomes. Participants represented many perspectives, including patients, clinicians, researchers, payers, health technology assessors, regulators, and drug development companies. The coreASTHMA core outcome set is a triumph. Even in a condition like asthma, where the most important outcomes for clinical research might seem self-evident, valuable insights on outcome selection were gained through multistakeholder engagement. I am confident that as these insights are adopted into clinical research, producing more relevant data
Green Park Collaborative and COPD Foundation Launch coreCOPD to Develop Consensus on Critical Outcomes for Stable COPD
News provided by
Share this article
Share this article
BALTIMORE, Dec. 23, 2020 /PRNewswire/ The Green Park Collaborative (GPC), a major initiative of the Center for Medical Technology Policy (CMTP), is partnering with The COPD Foundation to develop a core set of outcomes to be used in late phase clinical trials of therapies for stable chronic obstructive pulmonary disease (COPD). This initiative, coreCOPD, will engage patients, clinicians, researchers, regulators, payers, health technology assessors, product developers, and other key stakeholders in a structured consensus process to develop the core outcome set.